Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Biomarkers of Renal Cancer

NCT05785052 is registered in ClinicalTrials.gov with Biorek S.R.L. as lead sponsor.

NCT NCT05785052
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05785052 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Biomarkers of Renal Cancer
Lead sponsor
Biorek S.R.L.
Phase
Observational
Overall status
Unknown status
Start date
June 11, 2019
Completion date
June 30, 2026
Enrollment
1,000 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

angiomyolipoma, oncocytoma, renal cell carcinoma, tumor, solid